Inter-observer reliability of XXXX substance use disorders.

@entity4987 @entity61130 @entity2072 @entity148 @entity285 @entity734
AIMS: Although studies have examined the impact of changes made in @entity4987 on the estimated prevalence of @entity734 ( @entity734 ) diagnoses, there is limited evidence concerning the reliability of @entity4987 SUDs. We evaluated the inter-observer reliability of four @entity4987 SUDs in a sample in which we had previously evaluated the reliability of DSM-IV diagnoses, allowing us to compare the two systems. METHODS: Two different interviewers each assessed 173 subjects over a 2-week period using the Semi-Structured Assessment for @entity734 (SSADDA). Using the percent agreement and kappa (k) coefficient, we examined the reliability of @entity4987 lifetime @entity285 , opioid, @entity2072 , and @entity61130 use disorders, which we compared to that of SSADDA-derived DSM-IV @entity734 diagnoses. We also assessed the effect of additional lifetime @entity734 and lifetime mood or @entity148 diagnoses on the reliability of the @entity4987 @entity734 diagnoses. RESULTS: Reliability was good to excellent for the four disorders, with k values ranging from 0.65 to 0.94. Agreement was consistently lower for SUDs of mild severity than for moderate or severe disorders. @entity4987 @entity734 diagnoses showed greater reliability than DSM-IV diagnoses of abuse or @entity734 or @entity734 only. Co-occurring @entity734 and lifetime mood or @entity148 exerted a modest effect on the reliability of the @entity4987 @entity734 diagnoses. CONCLUSIONS: For @entity285 , opioid, @entity2072 and @entity61130 use disorders, @entity4987 criteria and diagnoses are at least as reliable as those of DSM-IV.
